|
1
|
Kaufman DS, Shipley WU and Feldman ASJL:
Bladder Cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar
|
|
2
|
Dong F, Xu T, Shen Y, Zhong S, Chen S,
Ding Q and Shen Z: Dysregulation of miRNAs in bladder cancer:
Altered expression with aberrant biogenesis procedure. Oncotarget.
8:27547–27568. 2017. View Article : Google Scholar
|
|
3
|
Park JC, Citrin DE, Agarwal PK and Apolo
AB: Multimodal management of muscle-invasive bladder cancer. Curr
Probl Cancer. 38:80–108. 2014. View Article : Google Scholar
|
|
4
|
Madersbacher S, Hochreiter W, Burkhard F,
Thalmann GN, Danuser H, Markwalder R and Studer UE: Radical
cystectomy for bladder cancer today - a homogeneous series without
neoadjuvant therapy. J Clin Oncol. 21:690–696. 2003. View Article : Google Scholar
|
|
5
|
Smith AB, Jaeger B, Pinheiro LC, Edwards
LJ, Tan HJ, Nielsen ME and Reeve BB: Impact of bladder cancer on
health-related quality of life. BJU Int. 121:549–557. 2018.
View Article : Google Scholar
|
|
6
|
Bajaj A, Martin B, Bhasin R, Hentz C,
Block AM, Harkenrider MM and Solanki AA: The impact of academic
facility type and case volume on survival in patients undergoing
curative radiation therapy for muscle-invasive bladder cancer. Int
J Radiat Oncol Biol Phys. 100:851–857. 2018. View Article : Google Scholar
|
|
7
|
Mitin T, Dengina N, Chernykh M, Usychkin
S, Gladkov O, Degnin C, Chen Y, Nosov D, Tsimafeyeu I, Thomas CR
Jr, et al: Management of muscle invasive bladder cancer with
bladder preservation in Russia: A survey-based analysis of current
practice and the impact of an educational workshop on clinical
expertise. J Cancer Educ. Mar 4–2020.(Epub ahead of print). doi:
10.1007/s13187-020-01728-y. View Article : Google Scholar
|
|
8
|
Shimura T: Acquired radioresistance of
cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat
Res (Tokyo). 52:539–544. 2011. View Article : Google Scholar
|
|
9
|
Sharda A, Rashid M, Shah SG, Sharma AK,
Singh SR, Gera P, Chilkapati MK and Gupta S: Elevated HDAC activity
and altered histone phospho-acetylation confer acquired
radio-resistant phenotype to breast cancer cells. Clin Epigenetics.
12:42020. View Article : Google Scholar
|
|
10
|
Anuja K, Kar M, Chowdhury AR, Shankar G,
Padhi S, Roy S, Akhter Y, Rath AK and Banerjee B: Role of telomeric
RAP1 in radiation sensitivity modulation and its interaction with
CSC marker KLF4 in colorectal cancer. Int J Radiat Biol.
96:790–802. 2020. View Article : Google Scholar
|
|
11
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: The 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar
|
|
12
|
Vlashi E and Pajonk F: Cancer stem cells,
cancer cell plasticity and radiation therapy. Semin Cancer Biol.
31:28–35. 2015. View Article : Google Scholar
|
|
13
|
Bighetti-Trevisan RL, Sousa LO, Castilho
RM and Almeida LO: Cancer stem cells: Powerful targets to improve
current anticancer therapeutics. Stem Cells Int. 2019:96180652019.
View Article : Google Scholar
|
|
14
|
Ishiguro T, Ohata H, Sato A, Yamawaki K,
Enomoto T and Okamoto K: Tumor-derived spheroids: Relevance to
cancer stem cells and clinical applications. Cancer Sci.
108:283–289. 2017. View Article : Google Scholar
|
|
15
|
Galoczova M, Coates P and Vojtesek B:
STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett.
23:122018. View Article : Google Scholar
|
|
16
|
Pattabiraman DR and Weinberg RA: Tackling
the cancer stem cells - what challenges do they pose? Nat Rev Drug
Discov. 13:497–512. 2014. View
Article : Google Scholar
|
|
17
|
Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab
T and Lin J: STAT3 signaling pathway is necessary for cell survival
and tumorsphere forming capacity in
ALDH+/CD133+ stem cell-like human colon
cancer cells. Biochem Biophys Res Commun. 416:246–251. 2011.
View Article : Google Scholar
|
|
18
|
Mao G, Yao Y and Kong Z: Long term
exposure to γ rays induces radioresistance and enhances the
migration ability of bladder cancer cells. Mol Med Rep.
18:5834–5840. 2018.
|
|
19
|
Chang R, He H, Mao G and Kong Z:
Upregulating DAB2IP expression via EGR-1 inhibition, a new approach
for overcoming fractionated-irradiation-induced cross-tolerance to
ionizing radiation and mitomycin C in tumor cells. Int J Radiat
Biol. 93:386–393. 2017. View Article : Google Scholar
|
|
20
|
Sen N, Che X, Rajamani J, Zerboni L, Sung
P, Ptacek J and Arvin AM: Signal transducer and activator of
transcription 3 (STAT3) and survivin induction by varicella-zoster
virus promote replication and skin pathogenesis. Proc Natl Acad Sci
USA. 109:600–605. 2012. View Article : Google Scholar
|
|
21
|
Yang Z, He L, Lin K, Zhang Y, Deng A, Yong
Liang Y, Li C and Wen T: The KMT1A-GATA3-STAT3 circuit is a novel
self-renewal signaling of human bladder cancer stem cells. Clin
Cancer Res. 23:6673–6685. 2017. View Article : Google Scholar
|
|
22
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar
|
|
23
|
Livak and Schmittgen, . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-DDct method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
24
|
Eun K, Ham SW and Kim H: Cancer stem cell
heterogeneity: origin and new perspectives on CSC targeting. BMB
Rep. 50:117–125. 2017. View Article : Google Scholar
|
|
25
|
Ahmad G and Amiji MM: Cancer stem
cell-targeted therapeutics and delivery strategies. Expert Opin
Drug Deliv. 14:997–1008. 2017. View Article : Google Scholar
|
|
26
|
Tran MN, Goodwin Jinesh G, McConkey DJ and
Kamat AM: Bladder cancer stem cells. Curr Stem Cell Res Ther.
5:387–395. 2010. View Article : Google Scholar
|
|
27
|
Abubaker K, Luwor RB, Zhu H, McNally O,
Quinn MA, Burns CJ, Thompson EW, Findlay JK and Ahmed N: Inhibition
of the JAK2/STAT3 pathway in ovarian cancer results in the loss of
cancer stem cell-like characteristics and a reduced tumor burden.
BMC Cancer. 14:3172014. View Article : Google Scholar
|
|
28
|
Gao L, Li FS, Chen XH, Liu QW, Feng J B,
Liu QJ and Su X: Radiation induces phosphorylation of STAT3 in a
dose- and time-dependent manner. Asian Pac J Cancer Prev.
15:6161–6164, 201. View Article : Google Scholar
|
|
29
|
Berdik C: Unlocking bladder cancer.
Nature. 551:S34–S35. 2017. View
Article : Google Scholar
|
|
30
|
Li JY, Li YY, Jin W, Yang Q, Shao ZM and
Tian XS: ABT-737 reverses the acquired radioresistance of breast
cancer cells by targeting Bcl-2 and Bcl-xL. J Exp Clin Cancer Res.
31:1022012. View Article : Google Scholar
|
|
31
|
Najafi M, Farhood B, Mortezaee K,
Kharazinejad E, Majidpoor J and Ahadi R: Hypoxia in solid tumors: A
key promoter of cancer stem cell (CSC) resistance. J Cancer Res
Clin Oncol. 146:19–31. 2020. View Article : Google Scholar
|
|
32
|
Ohishi T, Koga F and Migita T: Bladder
cancer stem-like cells: Their origin and therapeutic perspectives.
Int J Mol Sci. 17:172015. View Article : Google Scholar
|
|
33
|
Masliantsev K, Pinel B, Balbous A, Guichet
PO, Tachon G, Milin S, Godet J, Duchesne M, Berger A, Petropoulos
C, et al: Impact of STAT3 phosphorylation in glioblastoma stem
cells radiosensitization and patient outcome. Oncotarget.
9:3968–3979. 2017. View Article : Google Scholar
|
|
34
|
Park SY, Lee CJ, Choi JH, Kim JH, Kim JW,
Kim JY and Nam JS: The JAK2/STAT3/CCND2 Axis promotes colorectal
cancer stem cell persistence and radioresistance. J Exp Clin Cancer
Res. 38:3992019. View Article : Google Scholar
|
|
35
|
Huang S: Regulation of metastases by
signal transducer and activator of transcription 3 signaling
pathway: clinical implications. Clin Cancer Res. 13:1362–1366.
2007. View Article : Google Scholar
|
